(Q37252459)

19 August 2017

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance (English)

1 reference

19 August 2017

0 references

anti-retroviral agent

0 references

0 references

Benigno Rodriguez

8

0 references

Ronald Ellis

object named as

Ronald J Ellis

7

0 references

Scott Letendre

4

object named as

Scott Letendre

1 reference

19 August 2017

9

Robert W Coombs

1 reference

19 August 2017

1

Christina M Marra

1 reference

19 August 2017

11

Justin C McArthur

1 reference

19 August 2017

10

Giovanni Schifitto

1 reference

19 August 2017

Yu Zhao

2

1 reference

19 August 2017

David B Clifford

3

1 reference

19 August 2017

Scott Evans

5

1 reference

19 August 2017

Katherine Henry

6

1 reference

19 August 2017

Kevin Robertson

12

1 reference

19 August 2017

AIDS Clinical Trials Group 736 Study Team

13

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

19 August 2017

1 reference

19 August 2017

23

1 reference

19 August 2017

11

1 reference

19 August 2017

1359-1366

1 reference

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Changing incidence of central nervous system diseases in the EuroSIDA cohort

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Determining the extent of cognitive change after coronary surgery: a review of statistical procedures

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Antiretroviral therapy in HIV infection: are neurologically active drugs important?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Calculating correlation coefficients with repeated observations: Part 2--Correlation between subjects

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706549

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19424052

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/QAD.0B013E32832C4152

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19424052

1 reference